Polar Capital Holdings Plc - Q1 2021 holdings

$16.2 Billion is the total value of Polar Capital Holdings Plc's 336 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 100.0% .

 Value Shares↓ Weighting
BABA ExitALIBABA GROUP HLDG LTDcall$0-600
-100.0%
-0.00%
ITCI ExitINTRA CELLULAR THERAPIES INC$0-10,558
-100.0%
-0.00%
EHTH ExitEHEALTH INC$0-3,984
-100.0%
-0.00%
RGEN ExitREPLIGEN CORP$0-1,509
-100.0%
-0.00%
VCEL ExitVERICEL CORP$0-12,908
-100.0%
-0.00%
ExitWELLPOINT INCnote 2.750%10/1$0-100,000
-100.0%
-0.00%
TCMD ExitTACTILE SYS TECHNOLOGY INC$0-13,527
-100.0%
-0.00%
LHCG ExitLHC GROUP INC$0-3,377
-100.0%
-0.00%
ExitPINDUODUO INCnote 10/0$0-250,000
-100.0%
-0.01%
MGLN ExitMAGELLAN HEALTH INC$0-14,638
-100.0%
-0.01%
MIXT ExitMIX TELEMATICS LTDsponsored adr$0-101,510
-100.0%
-0.01%
ExitWORKDAY INCnote 0.250%10/0$0-1,000,000
-100.0%
-0.01%
GOLD ExitBARRICK GOLD CORP$0-64,421
-100.0%
-0.01%
AEM ExitAGNICO EAGLE MINES LTD$0-23,670
-100.0%
-0.01%
ExitSQUARE INCnote 0.500% 5/1$0-700,000
-100.0%
-0.01%
ExitZILLOW GROUP INCnote 0.750% 9/0$0-700,000
-100.0%
-0.01%
YNDX ExitYANDEX N V$0-38,693
-100.0%
-0.02%
ALXO ExitALX ONCOLOGY HLDGS INC$0-32,500
-100.0%
-0.02%
TVTX ExitTRAVERE THERAPEUTICS INC$0-125,000
-100.0%
-0.02%
API ExitAGORA INCads$0-89,625
-100.0%
-0.02%
ExitSYNAPTICS INCnote 0.500% 6/1$0-3,000,000
-100.0%
-0.02%
VNET Exit21VIANET GROUP INCsponsored ads a$0-121,080
-100.0%
-0.02%
ExitBLACKLINE INCnote 0.125% 8/0$0-2,500,000
-100.0%
-0.03%
SYY ExitSYSCO CORP$0-67,782
-100.0%
-0.03%
COUP ExitCOUPA SOFTWARE INC$0-16,717
-100.0%
-0.03%
SNPS ExitSYNOPSYS INC$0-22,660
-100.0%
-0.04%
ALLO ExitALLOGENE THERAPEUTICS INC$0-251,473
-100.0%
-0.04%
GRUB ExitGRUBHUB INC$0-86,678
-100.0%
-0.04%
RCKT ExitROCKET PHARMACEUTICALS INC$0-125,000
-100.0%
-0.04%
ExitTWITTER INCnote 0.250% 6/1$0-6,000,000
-100.0%
-0.04%
IPGP ExitIPG PHOTONICS CORP$0-34,918
-100.0%
-0.05%
TMO ExitTHERMO FISHER SCIENTIFIC INC$0-18,903
-100.0%
-0.05%
LLY ExitLILLY ELI & CO$0-64,908
-100.0%
-0.07%
PRAH ExitPRA HEALTH SCIENCES INC$0-95,000
-100.0%
-0.07%
PTCT ExitPTC THERAPEUTICS INC$0-200,000
-100.0%
-0.07%
IQV ExitIQVIA HLDGS INC$0-86,406
-100.0%
-0.09%
A ExitAGILENT TECHNOLOGIES INC$0-157,314
-100.0%
-0.11%
IAC ExitIAC INTERACTIVECORP NEW$0-101,720
-100.0%
-0.12%
CRNC ExitCERENCE INC$0-196,932
-100.0%
-0.12%
CI ExitCIGNA CORP NEW$0-96,529
-100.0%
-0.12%
BDX ExitBECTON DICKINSON & CO$0-80,594
-100.0%
-0.12%
ADCT ExitADC THERAPEUTICS SA$0-683,837
-100.0%
-0.13%
ExitTRILLIUM THERAPEUTICS INC$0-1,532,922
-100.0%
-0.14%
ExitMACQUARIE INFRASTRUCTURE CORnote 2.000%10/0$0-23,500,000
-100.0%
-0.14%
CFXA ExitCOLFAX CORPunit 01/15/2022t$0-150,000
-100.0%
-0.15%
SPLK ExitSPLUNK INC$0-211,584
-100.0%
-0.22%
OXFD ExitOXFORD IMMUNOTEC GLOBAL PLC$0-2,568,385
-100.0%
-0.27%
FLIR ExitFLIR SYS INC$0-1,050,468
-100.0%
-0.28%
DASH ExitDOORDASH INCcl a$0-337,196
-100.0%
-0.29%
TER ExitTERADYNE INC$0-439,800
-100.0%
-0.32%
KEYS ExitKEYSIGHT TECHNOLOGIES INC$0-408,016
-100.0%
-0.33%
MDLA ExitMEDALLIA INC$0-1,639,530
-100.0%
-0.33%
IMVT ExitIMMUNOVANT INC$0-1,377,925
-100.0%
-0.39%
ESTC ExitELASTIC N V$0-480,081
-100.0%
-0.42%
TSLA ExitTESLA INC$0-116,588
-100.0%
-0.50%
XLNX ExitXILINX INC$0-588,727
-100.0%
-0.51%
HUM ExitHUMANA INC$0-221,640
-100.0%
-0.55%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP15Q2 20245.8%
APPLE INC15Q2 20244.7%
NVIDIA CORPORATION15Q2 20247.8%
ALPHABET INC15Q2 20243.3%
META PLATFORMS INC15Q2 20244.0%
ALPHABET INC15Q2 20243.0%
ADVANCED MICRO DEVICES INC15Q2 20243.0%
ARCH CAP GROUP LTD15Q2 20242.5%
AMAZON COM INC15Q2 20242.3%
CHUBB LIMITED15Q2 20241.9%

View Polar Capital Holdings Plc's complete holdings history.

Latest significant ownerships (13-D/G)
Polar Capital Holdings Plc Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Arcutis Biotherapeutics, Inc.February 13, 20246,297,6886.7%
AVADEL PHARMACEUTICALS PLCFebruary 13, 20246,751,7827.5%
Celldex Therapeutics, Inc.February 13, 20243,135,8715.7%
NanoString Technologies IncFebruary 13, 20243,975,0008.3%
Revance Therapeutics, Inc.February 13, 20243,169,2393.6%
Spyre Therapeutics, Inc.February 13, 2024500,0001.0%
Aeglea BioTherapeutics, Inc.July 28, 20233,936,1985.0%
INFINITY PHARMACEUTICALS, INC.February 14, 20232,071,2422.3%
Quotient LtdSold outFebruary 14, 202300.0%
Summit Therapeutics Inc.Sold outFebruary 14, 202300.0%

View Polar Capital Holdings Plc's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G2024-02-13
SC 13G2024-02-13

View Polar Capital Holdings Plc's complete filings history.

Compare quarters

Export Polar Capital Holdings Plc's holdings